Skip to content

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics.

Cristiano Chaves, Rafael G. Dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak

Frontiers in Psychiatry November 6, 2024 DOI: 10.3389/fpsyt.2024.1485337 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Commentary Peer reviewed
Topics 5-MeO-DMT DMT
Keywords Psychedelics Mental health treatment Pharmacology Therapeutic research
Citations 11
Key points Argues that defining classical psychedelics mainly by serotonin 5-HT2A receptor activity oversimplifies DMT's pharmacology, overlooking its broader receptor interactions, lack of tolerance, and distinct subjective experiences. The authors contend that DMT, a naturally occurring tryptamine and the main component of the "wine of jurema" used in ancient Brazilian shamanic rituals, deserves recognition for these unique features.

Abstract

The "wine of jurema", used in ancient Brazilian shamanic rituals, is rich in N,N-dimethyltryptamine (DMT), a naturally occurring tryptamine like serotonin and melatonin. Widely found in plants and animals, DMT is the main component of some botanical tisanes used for centuries as a channel of communication with the otherworld (1, 2). Despite being classified as a "classical psychedelic” (2-4), DMT’s unique effects are often overlooked due to an overemphasis on serotonin (5HT) 2A receptors as the key pharmacological feature of serotoninergic psychedelics. This simplification ignores DMT’s broader receptor interactions, lack of tolerance, and distinct subjective experiences.

Citations in the library

Cited by 7

and 2 more in the library

Cites 79

and 74 more in the library

Explore topics